Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sunshine Biopharma (SBFM) Shares Repurchased (2016 - 2024)

Sunshine Biopharma's Shares Repurchased history spans 10 years, with the latest figure at $3.1 million for Q1 2024.

  • For Q1 2024, Shares Repurchased rose 519.48% year-over-year to $3.1 million; the TTM value through Dec 2024 reached $3.1 million, up 480.19%, while the annual FY2024 figure was $3.1 million, 480.19% up from the prior year.
  • Shares Repurchased reached $3.1 million in Q1 2024 per SBFM's latest filing, up from $34321.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $3.1 million in Q1 2024 to a low of $34321.0 in Q3 2023.
  • Average Shares Repurchased over 3 years is $944948.5, with a median of $302911.0 recorded in 2022.
  • Peak YoY movement for Shares Repurchased: soared 411.94% in 2023, then surged 519.48% in 2024.
  • A 3-year view of Shares Repurchased shows it stood at $99000.0 in 2022, then plummeted by 65.33% to $34321.0 in 2023, then skyrocketed by 9047.9% to $3.1 million in 2024.
  • Per Business Quant, the three most recent readings for SBFM's Shares Repurchased are $3.1 million (Q1 2024), $34321.0 (Q3 2023), and $506822.0 (Q1 2023).